Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Biopharma Wins Reprieve On US FDA 'Intended Use' Rule

Mar 18 2017

• By Brenda Sandburg

FDASignBldg21Entrance_1200x675

Related Content

US FDA Clarifies ‘Intended Use’ Policy For Approved Products

Jan 17 2017

‘Intended Use’ Rule: Industry Urges US FDA To Revoke ‘Totality Of Evidence’ Standard

Feb 13 2017

First Amendment Does Not Block Off-Label Enforcement Actions, FDA Reiterates

Jan 22 2017

FDA Off-Label Reg Changes For Drugs Could Be Driven By Tobacco Policy

Oct 07 2015

Off-Label Communications: Industry, FDA Debate Role Of Peer Review

Nov 10 2016

Additional Topics

United States Advertising, Marketing & Sales FDA Regulation BioPharmaceutical

More from Marketing & Advertising

More from Compliance

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window